199 related articles for article (PubMed ID: 37405217)
1. Using Liquid Biopsy to Predict Relapse After Radiotherapy in Squamous Cell Head-Neck and Esophageal Cancer.
Koukourakis IM; Xanthopoulou E; Koukourakis MI
Cancer Diagn Progn; 2023; 3(4):403-410. PubMed ID: 37405217
[TBL] [Abstract][Full Text] [Related]
2. Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy.
Muhanna N; Eu D; Chan HHL; Douglas C; Townson JL; Di Grappa MA; Mohamadi RM; Kelley SO; Bratman SV; Irish JC
BMC Cancer; 2021 Oct; 21(1):1075. PubMed ID: 34600526
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma.
Wilson HL; D'Agostino RB; Meegalla N; Petro R; Commander S; Topaloglu U; Zhang W; Porosnicu M
Oncologist; 2021 Feb; 26(2):e279-e289. PubMed ID: 33098199
[TBL] [Abstract][Full Text] [Related]
4. Circulating Plasma Cell-free DNA (cfDNA) as a Predictive Biomarker for Radiotherapy: Results from a Prospective Trial in Head and Neck Cancer.
Koukourakis MI; Xanthopoulou E; Koukourakis IM; Fortis SP; Kesesidis N; Karakasiliotis I; Baxevanis CN
Cancer Diagn Progn; 2023; 3(5):551-557. PubMed ID: 37671311
[TBL] [Abstract][Full Text] [Related]
5. Cell-Free Circulating (Tumor) DNA before Surgery as a Prognostic Factor in Non-Metastatic Colorectal Cancer: A Systematic Review.
Schraa SJ; van Rooijen KL; Koopman M; Vink GR; Fijneman RJA
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565347
[TBL] [Abstract][Full Text] [Related]
6. Monitoring levels of circulating cell-free DNA in patients with metastatic colorectal cancer as a potential biomarker of responses to regorafenib treatment.
Pastor B; André T; Henriques J; Trouilloud I; Tournigand C; Jary M; Mazard T; Louvet C; Azan S; Bauer A; Roch B; Sanchez C; Vernerey D; Thierry AR; Adenis A
Mol Oncol; 2021 Sep; 15(9):2401-2411. PubMed ID: 33934494
[TBL] [Abstract][Full Text] [Related]
7. Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis.
He Y; Ma X; Chen K; Liu F; Cai S; Han-Zhang H; Hou T; Xiang J; Peng J
Cancer Manag Res; 2020; 12():1621-1630. PubMed ID: 32184665
[TBL] [Abstract][Full Text] [Related]
8. The effect of surgical trauma on circulating free DNA levels in cancer patients-implications for studies of circulating tumor DNA.
Henriksen TV; Reinert T; Christensen E; Sethi H; Birkenkamp-Demtröder K; Gögenur M; Gögenur I; Zimmermann BG; ; Dyrskjøt L; Andersen CL
Mol Oncol; 2020 Aug; 14(8):1670-1679. PubMed ID: 32471011
[TBL] [Abstract][Full Text] [Related]
9. Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer.
Azad TD; Chaudhuri AA; Fang P; Qiao Y; Esfahani MS; Chabon JJ; Hamilton EG; Yang YD; Lovejoy A; Newman AM; Kurtz DM; Jin M; Schroers-Martin J; Stehr H; Liu CL; Hui AB; Patel V; Maru D; Lin SH; Alizadeh AA; Diehn M
Gastroenterology; 2020 Feb; 158(3):494-505.e6. PubMed ID: 31711920
[TBL] [Abstract][Full Text] [Related]
10. Individualized circulating tumor DNA monitoring in head and neck squamous cell carcinoma.
Kogo R; Manako T; Iwaya T; Nishizuka S; Hiraki H; Sasaki Y; Idogawa M; Tokino T; Koide A; Komune N; Yasumatsu R; Nakagawa T
Cancer Med; 2022 Nov; 11(21):3960-3968. PubMed ID: 35352507
[TBL] [Abstract][Full Text] [Related]
11. Liquid biopsies based on cell-free DNA as a potential biomarker in head and neck cancer.
Rapado-González Ó; Rodríguez-Ces AM; López-López R; Suárez-Cunqueiro MM
Jpn Dent Sci Rev; 2023 Dec; 59():289-302. PubMed ID: 37680614
[TBL] [Abstract][Full Text] [Related]
12. Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management.
Elazezy M; Joosse SA
Comput Struct Biotechnol J; 2018; 16():370-378. PubMed ID: 30364656
[TBL] [Abstract][Full Text] [Related]
13. Current applications and challenges of circulating tumor DNA (ctDNA) in squamous cell carcinoma of the head and neck (SCCHN).
Galot R; Machiels JH
Cancer Treat Rev; 2020 Apr; 85():101992. PubMed ID: 32092618
[TBL] [Abstract][Full Text] [Related]
14. Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.
Vandekerkhove G; Struss WJ; Annala M; Kallio HML; Khalaf D; Warner EW; Herberts C; Ritch E; Beja K; Loktionova Y; Hurtado-Coll A; Fazli L; So A; Black PC; Nykter M; Tammela T; Chi KN; Gleave ME; Wyatt AW
Eur Urol; 2019 Apr; 75(4):667-675. PubMed ID: 30638634
[TBL] [Abstract][Full Text] [Related]
15. Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC).
Economopoulou P; Spathis A; Kotsantis I; Maratou E; Anastasiou M; Moutafi MK; Kirkasiadou M; Pantazopoulos A; Giannakakou M; Edelstein DL; Sloane H; Fredebohm J; Jones FS; Kyriazoglou A; Gavrielatou N; Foukas P; Panayiotides I; Psyrri A
Oral Oncol; 2023 Apr; 139():106358. PubMed ID: 36871349
[TBL] [Abstract][Full Text] [Related]
16. Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study.
Haider Z; Wästerlid T; Spångberg LD; Rabbani L; Jylhä C; Thorvaldsdottir B; Skaftason A; Awier HN; Krstic A; Gellerbring A; Lyander A; Hägglund M; Jeggari A; Rassidakis G; Sonnevi K; Sander B; Rosenquist R; Tham E; Smedby KE
Front Oncol; 2023; 13():1176698. PubMed ID: 37333831
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma.
Burgener JM; Zou J; Zhao Z; Zheng Y; Shen SY; Huang SH; Keshavarzi S; Xu W; Liu FF; Liu G; Waldron JN; Weinreb I; Spreafico A; Siu LL; de Almeida JR; Goldstein DP; Hoffman MM; De Carvalho DD; Bratman SV
Clin Cancer Res; 2021 Aug; 27(15):4230-4244. PubMed ID: 34158359
[TBL] [Abstract][Full Text] [Related]
18. Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer.
Corradetti MN; Torok JA; Hatch AJ; Xanthopoulos EP; Lafata K; Jacobs C; Rushing C; Calaway J; Jones G; Kelsey CR; Nixon AB
Adv Radiat Oncol; 2019; 4(4):748-752. PubMed ID: 31673668
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of early kinetics of ctDNA combined with cfDNA and serum CEA for EGFR-TKI treatment in advanced non-small cell lung cancer.
Zheng J; Wang Y; Hu C; Zhu M; Ii J; Lin C; Lu C; Dou Y; Zhao C; Zhang Y; Wu D; Li L; Tang H; He T; Pan C; Han R; He Y
Thorac Cancer; 2022 Nov; 13(22):3162-3173. PubMed ID: 36193794
[TBL] [Abstract][Full Text] [Related]
20. Liquid biopsy: current technology and clinical applications.
Nikanjam M; Kato S; Kurzrock R
J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
